MIOX is modulated by specificity protein-1 (Sp-1), a transcription factor which could serve as a potential site for the development of interventions targeting the progression of DKD as inhibition of Sp-1 has been shown to reduce ROS production (90). Here, SP1 is linked to diabetic kidney disease.